The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: A critical and theoretical review

Neuropsychology Review

Volumn 12, Issue 2, 2002, Pages 65-109

  Zec, Ronald F ^a   Trivedi, Mehul A ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Aging; Cognition; Estrogen therapy; Memory; Review

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; NEUROTRANSMITTER; PROGESTERONE; RALOXIFENE; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGING; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CLINICAL STUDY; COGNITION; DEMENTIA; DEPRESSION; EDUCATION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; MEMORY; METHODOLOGY; MOOD DISORDER; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; OBSERVATION; OUTCOMES RESEARCH; POSTMENOPAUSE; REVIEW; RISK BENEFIT ANALYSIS; SHORT COURSE THERAPY; VASODILATATION; VERBAL MEMORY; BRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GENETICS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; COGNITION; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS; POSTMENOPAUSE; RALOXIFENE; RANDOMIZED CONTROLLED TRIALS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0036615277     PISSN: 10407308     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016880127635     Document Type: Review

References (179)

1. Applebaum-Bowden, D., McLean, P., Steinmetz, A., Fontana, D., Matthys, C., Warnick, G. R., Cheung, M., Albers, J. J., and Hazzard, W. R. (1989). Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. Journal of Lipid Research 30: 1895-1906.
2. Asthana, S., Baker, L. D., Craft, S., Stanczyk, F. Z., Veith, R. C., Raskind, M. A., and Plymate, S. R. (2001). High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology 57: 605-612.
3. Asthana, S., Cfart, S., Baker, L. D., Raskind, M. A., Birnbaum, B. S., Lofgreen, C. P., Veith, R. C., and Plymate, S. R. (1999). Cognitive and neuroendocrine response to transdermal estrogen in post-menopausal women with Alzheimer's disease: Results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24: 657-677.
4. Aylward, M. (1973). Plasma tryptophan levels and mental depression in postmenopausal subjects: Effects of oral piperazine-oestrone sulphate. International Research Communications System Medical Science 1: 30-34.
5. Baldereschi, M., Di Carlo, A., Lepore, V., Bracco, L., Maggi, S., Grigoletto, F., Scarlato, G., and Amaducci, L. (1998). Estrogen replacement therapy and Alzheimer's Disease in the Italian longitudinal study on aging. Neurology 50: 996-1002.
6. Barrett-Connor, E., and Kritz-Silverstein, D. (1993). Estrogen replacement therapy and cognitive function in older women. JAMA 269: 2637-2641.
7. Behl, C. R., Widmann, M. D., Trapp, T., and Holsboer, F. (1995). 17-Beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochemistry Biophysiology Research Communication 216: 473-482.
8. Belchetz, P. (1994). Hormonal treatment of postmenopausal women. New England Journal of Medicine 330: 1062-1071.
9. Binder, E. F., Schechtman, K. B., Birge, S. J., Williams, D. B., and Kohrt, W. M. (2001). Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38: 137-146.
10. Birge, S. J. (1997). The role of estrogen in the treatment of Alzheimer's disease. Neurology 48: S36-S41.
11. Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: long-term potential in the hippocampus. Nature 361: 31-39.
12. Brinton, R. D., Proffit, P., Tran, J., and Luu, R. (1997a). Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Experimental Neurology 147: 211-220.
13. Brinton, R. D., Tran, J., Proffit, P., and Montoya, M. (1997b). 17 beta-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochemistry Research 11: 1339-1351.
14. Broadbent, D. E., Cooper, P. F., FitzGerald, P., and Parkes, K. R. (1982). The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology 21: 1-16.
15. Buist, D. S., LaCroix, A. Z., Newton, K. M., and Keenan, N. L. (1999). Are long-term hormone replacement therapy users different from short-term and never-users. American Journal of Epidemiology 149: 275-281.
16. Caldwell, B. M. (1954). An evaluation of psychological effects of sex hormone administration in aged women. II: Results of therapy after eighteen months. Journal of Gerontology 9: 168-174.
17. Caldwell, B. M., and Watson, R. I. (1952). An evaluation of psychological effects of sex hormone administration in aged women. I: Results of therapy after six months. Journal of Gerontology 7: 228-244.
18. Campbell, S., and Whitehead, M. (1977). Oestrogen therapy and the menopausal syndrome Clinics of Obstetrics and Gynecology 4(1): 31-47.
19. Carlson, L. E., and Sherwin, B. B. (1998). Steroid hormones, memory, and mood in a healthy older elderly population. Psychoneuroendocrinology 23(6): 583-603.
20. Chang, R. J., Plouffe, L., and Schaffer, K. (1994). Physiology of menopause. In Lorrain, J., Plouffe, L., Ravnikar, V., Speroff, L., and Watt, N. (eds.), Comprehensive Management of Menopause, Springer, New York.
21. Chung, S. K., Pfaff, D. W., and Cohen, R. S. (1988). Estrogen-induced alteration in synaptic morphology in the midbrain central gray. Experimental Brain Research 69: 522-530.
22. Dennerstein, L., and Burrows, G. (1986). Psychological effects of progestogens in the post-menopausal years. Maturitas 8: 101-106.
23. Diaz, H., Lorenzo, A., Carrer, H. F., and Caceres, A. (1992). Time lapse study of neurite growth in hypothalamic dissociated neurons in culture: Sex differences and estrogen effects. Journal of Neuroscience Research 33: 266-281.
24. Ditkoff, E. C., Crary, W. G., Cristo, M., and Lobo, R. A. (1991). Estrogen improves psychological function in asymptomatic postmenopausal women. Obstetrics and Gynecology 78(6): 991-995.
25. Dohanich, G. P., Fader, A. J., and Javorsky, D. J. (1994). Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats. Behavioral Neuroscience 108: 988-992.
26. Doraiswamy, P. M. (1997). Gender, concurrent estrogen use and cognition in AD. International Journal of Geriatric Psychopharmacology 1: 34-37.
27. Duka, T., Tasker, R., and McGowan, J. F. (2000). The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149: 129-139.
28. Erlanger, D. M., Kutner, K. C., and Jacobs, A. R. (1999). Hormones and cognition: Current concepts and issues in neuropsychology. Neuropsychology Review 9(4): 175-207.
29. Fedor-Freybergh, P. (1977). The influence of oestrogens on the well-being and mental performance of climacteric and postmenopausal women. Acta Obstetrica Gynecologica Scandinavica 64: 1-91.
30. Ferreira, A., and Caceres, A. (1991). Estrogen enhanced growth: Evidence for a selective induction of tau and stable microtubules. Journal of Neuroscience 11: 392-400.
31. Fillenbaum, G. G., Hanlon, J. T., Landerman, L. R., and Schmader, K. E. (2001). Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. American Journal of Epidemiology 153: 137-144.
32. Fillit, H. M. (1994). Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women. Annals of the New York Acadamy of Sciences 743: 233-239.
33. Fillit, H., Weinreb, H., Cholst, I., Luine, V., McEwen, B. S., Amador, R., and Zabriskie, J. (1986). Observations in a preliminary open trial of estradiol therapy for senile dementia of the Alzheimer's type. Psychoneuroendocrinology 11: 337-345.
34. Foy, M. R., Henderson, V. W., Berger, T. W., and Thompson, R. F. (2000). Estrogen and neural plasticity. Current Directions in Psychological Science 9: 148-152.
35. Foy, M. R., Xu, J., Xie, X., Brinton, R. D., Thompson, R. F., and Berger, T. W. (1999). 17B-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. Journal of Neurophysiology 81: 925-929.
36. Funk, J. L., Mortel, K. F., and Meyer, J. S. (1991). Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 2: 268-272.
37. Gangar, K. F., Vyas, S., Whitehead, M., Crook, D., Meire, H., and Campbell, S. (1991). Pulsivity index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 338: 839-842.
38. Gannon, L. R. (1999). Women and Aging: Transcending the Myths, Routledge, New York.
39. Geerlings, M. I., Ruitenberg, A., Witteman, J. C. M., van Swieten, J. C., Hofman, A., van Duijn, C. M., Breteler, M. M. B., and Launer, L. J. (2001). Reproductive period and risk of dementia in post-menopausal women. JAMA 285: 1475-1481.
40. Gibbs, R. B., Hashash, A., and Johnson, D. A. (1997). Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Research 749: 143-146.
41. Goebel, J. A., Birge, S. J., Price, S. C., Hanson, J. M., and Fishel, D. G. (1995). Estrogen replacement therapy and postural stability in the elderly. American Journal of Otology 16: 470-474.
42. Goodman, Y., Bruce, A. J., Cheng, B., and Mattson, M. P. (1996). Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. Journal of Neurochemistry 66: 1836-1844.
43. Gordon, H. W., Corbin, E. D., and Lee, P. A. (1986). Changes in specialized cognitive function following changes in hormone levels. Cortex 22: 399-415.
44. Gordon, H. W., and Lee, P. A. (1993). No differences in cognitive performance between the phases of the menstrual cycle. Psychoneuroendocrinology 18: 521-531.
45. Gould, E., Woolley, C. S., Frankfurt, M., and Mcewan, B. S. (1990). Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. Journal of Neuroscience 10: 1286-1291.
46. Green, P. S., Gridley, K. E., and Simpkins, J. W. (1996). Estradiol protects against beta-amyloid (25-35)-inducted toxicity in Sk-N-SH human neuroblastoma cells. Neuroscience Letters 218: 165-168.
47. Grodstein, F., Chen, J., Pollen, D. A., Albert, M. S., Wilson, R. S., Folstein, M. F., Evans, D. A., and Stampfer, M. J. (2000). Post-menopausal hormone therapy and cognitive function in healthy older women. Journal of the American Geriatrics Society 48: 746-752.
48. Hackman, B. W., and Galbraith, D. (1976). Replacement therapy with piperazine oestrone sulfate ("Harmogen") and its effect on memory. Current Medical Research and Opinion 4: 303-306.
49. Halbreich, U. (1997). Role of estrogen in postmenopausal depression. Neurology 48(Suppl. 7): S16-S20.
50. Halpern, D. F. (1992). Sex Differences in Cognitive Abilities, 2nd edn., Erlbaum, Hillsdale, NJ.
51. Haskell, S. G., Richardson, E. D., and Horwitz, R. I. (1997). The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature. Journal of Clinical Epidemiology 50: 1249-1264.
52. Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elbe, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R. A., Hake, A. M., and Farlow, M. R. (2000). Estrogen for Alzheimer's disease in women: Randomized, double blind, placebo-controlled trial. Neurology 54: 295-301.
53. Henderson, V. W., Watt, L., and Buckwalter, J. G. (1996). Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 21: 421-430.
54. Higgins, G. A., Large, C. H., Rupniak, H. T., and Barnes, J. C. (1997). Apolipoprotein E and Alzheimer's disease: A review of recent studies. Pharmacology Biochemistry and Behavior 56: 675-685.
55. Hines, M., Chiu, L., McAdams, L. A., Bentler, P. M., and Lipcamon, J. (1992). Cognition and the corpus callosum: Verbal fluency, visuospatial ability, and language lateralization related to midsagittal surface areas of callosal subregions. Behavioral Neuroscience 106: 3-14.
56. Hogervorst, E., Boshuisen, M., Riedel, W., Willeken, C., and Jolles, J. (1999). 1998 Curt P. Richter Award. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendrocrinology 24: 43-68.
57. Hogervorst, E., Williams, J., Budge, M., Riedel, W., and Jolles, J. (2000). The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: A meta-analysis. Neuroscience 101: 485-512.
58. Honjo, H., Ogino, Y., Naitoh, K., Urabe, M., Kitawaki, J., Yasuda, J., Yamamoto, T., Ishihara, S., Okada, H., Yonezawa, T., Hayashi, K., and Nambara, T. (1989). In vivo effects of estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). Journal of Steroid Biochemistry and Molecular Biology 34: 521-525.
59. Honjo, H., Ogino, Y., Naitoh, K., et al. (1993). An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: A placebo-controlled double-blind study. Journal of the Japanese Menopause Society 1: 167-171.
60. Honjo, H., Tamura, T., Matsumoto, Y., Kawata, M., Ogino, Y., Tanaka, K., Yamamoto, T., Ueda, S., and Okada, H. (1992). Estrogen as a growth factor to central nervous cells: Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber. Journal of Steroid Biochemical Molecular Biology 41: 633-635.
61. Honjo, H., Tanaka, K., Kashiwagi, T., Urabe, M., Okada, H., Hayashi, M., and Hayashi, K. (1995). Senile dementia-Alzheimer's type and estrogen. Hormone Metabolism Research 27: 204-207.
62. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., and Vittinghoff, E., for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613.
63. Jacobs, D. M., Tang, M. X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., Gurland, B., and Mayeux, R. (1998). Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50: 368-373.
64. Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J., Gavaghan, D. J., and McQuay, H. J. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 17: 1-12.
65. Jaffe, A. B., Toran-Allerand, C., Greengard, P., and Gandy, S. E. (1994). Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. Journal of Biological Chemistry 269: 13065-13068.
66. Janowsky, J. S., Chevez, B., and Orwoll, E. (2000). Sex steroids modify working memory. Journal of Cognitive Neuroscience 12: 407-414.
67. Kampen, D. L., and Sherwin, B. B. (1994). Estrogen use and verbal memory in healthy postmenopausal women. Obstetrics and Gynecology 83: 979-983.
68. Keenan, P. A., Ezzat, W. H., Ginsburg, K., and Moore, G. J. (2001). Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 26: 577-590.
69. Kimura, D. (1995). Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Hormones and Behavior 29: 312-321.
70. Klaber, E. L., Broverman, D. M., Vogel, W., and Kobayashi, Y. (1979). Estrogen therapy for severe persistent depression in women. Archives of General Psychiatry 36: 550-554.
71. Lark, S. M. (1995). The Estrogen Decision: Self Help Book, Celestial Arts, Berkeley, CA.
72. Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R., Dartigues, J. F., Kragh-Sorensen, P., Lobo, A., Martinez-Lage, J. M., Stijnen, T., and Hofman, A. (1999). Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. Neurology 52: 78-84. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.
73. LeBlanc, E. S., Janowsky, J., Chan, B. K. S., and Nelson, H. D. (2001). Hormone replacement therapy and cognition: Systematic review and meta-analysis. JAMA 285: 1489-1499.
74. Lezak, M. D. (1995). Neuropsychological Assessment, 3rd ed., Oxford University Press, Oxford.
75. Lindsay, R. (1991). Why do oestrogens prevent bone loss? Baillieres Clinical Obstetrics and Gynaecology 5: 837-852.
76. Linn, M. C., and Peterson, A. C. (1985). Emergence and characterization of the sex differences in spatial ability: A meta-analysis. Child Development 56: 1479-1498.
77. Linzmayer, L., Semlitsch, H. V., Saletu, B., Bock, G., Saletu-Zyhlarz, G., Zoghlami, A., Gruber, D., Metka, M., Huber, J., Oettel, M., Graser, T., and Grunberger, J. (2001). Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung 51: 238-245.
78. Lorenzo, A., Diaz, H., Carrer, H., and Caceres, A. (1992). Amygdala neurons in vitro: Neurite growth and the effects of estradiol. Journal of Neuroscience Research 33: 418-435.
79. Loy, R., Gerlach, J. L., and Mcewan, B. S. (1988). Autoradiographic localization of estradiol binding neurons in the rat hippocampal formation and entorhinal cortex. Brain Research 467: 245-251.
80. Luine, V. N. (1985). Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Experimental Neurology 59: 484-490.
81. Luine, V. N., Khylchevskaya, R. I., and McEwen, B. S. (1975). Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Research 86: 293-306.
82. Maas, D., Jochen, A., and Lalande, B. (1997). Age-related changes in male gonadal function: Implications for therapy. Drugs Ageing 11: 45-60.
83. Maccoby, E. E., and Jacklin, C. N. (1974). The Psychology of Sex Differences, Stanford University Press, Stanford, CA.
84. Maki, P. M., and Resnick, S. M. (2000). Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiology of Aging 21: 373-383.
85. Maki, P., Zonderman, A., and Resnick, S. (2001). Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. American Journal of Psychiatry 158: 227-233.
86. Manly, J. J., Merchant, C. A., Jacobs, D. M., Small, S. A., Bell, K., Ferin, M., and Mayeux, R. (2000). Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54: 833-837.
87. Manson, J. E., and Martin, K. A. (2001). Postmenopausal hormone-replacement therapy. New England Journal of Medicine 345: 34-40.
88. Marder, K., and Sano, M. (2000). Estrogen to treat Alzheimer's disease: Too little, too late? So what's a woman to do? Neurology 54: 2035-2037.
89. Matthews, K., Cauley, J., Yaffe, K., and Zmuda, J. M. (1999). Estrogen replacement therapy and cognitive decline in older community women. Journal of the American Geriatric Society 17: 518-523.
90. McEwen, B. S., and Alves, S. E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews 20: 279-307.
91. McEwen, B. S., and Woolley, C. S. (1994). Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Experimental Gerontology 29: 431-436.
92. McKinlay, S. M., and McKinlay, J. B. (1989). The impact of menopause and social factors on health. In Hammond, C. B., Hasseltine, F. P., and Schiff, I. (eds.), Menopause: Evaluation, Treatment, and Health Concerns, Alan Liss, New York, pp. 111-119.
93. Meilahn, E. N., Becker, R. C., and Corrao, J. M. (1995). Primary prevention of coronary heart disease. Cardiology 86: 286-298.
94. Morse, K., Scheff, S. W., and DeKosky, S. T. (1986). Gonadal steroids influence axon sprouting in the hippocampal dentate gyms: A sexually dimorphic response. Experimental Neurology 94: 649-658.
95. Mosca, L., Collins, P., Herrington, D. H., Mendelsohn, M. E., Pasternak, R. C., Robertson, R. M., Schenck-Gustafsson, K., Smith, S. C., Taubert, K. A., and Wenger, N. K. (2001). AHA science advisory. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 104: 499-503.
96. Mulner, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., Grundman, M., Thomas, R., and Thal, L. J. (2000). Estrogen replacement therapy for the treatment of mild to moderate Alzheimer's Disease: A randomized, double blind, placebo-controlled trial. JAMA 283: 1007-1015.
97. Murphy, D. D., Cole, N. B., Greenberger, V., and Segal, M. (1998). Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. Journal of Neuroscience 18: 2550-2559.
98. Natale, V., Albertazzi, P., Zini, M., and Di Micco, R. (2001). Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations. British Journal of Obstetrics and Gynaecology 108: 286-290.
99. Nickelsen, T., Lufkin, E. G., Riggs, B. L., Cox, D. A., and Crook, T. H. (1999). Raloxifence hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 24: 115-128.
100. Nilsen, J., Mor, G., and Naftolin, F. (2000). Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. Journal of Neurobiology 43: 64-78.
101. O'Connell, M. B. (1995). Pharmacokinetic and pharmacologic variation between different estrogen products. Journal of Clinical Pharmacology 35: 18S-24S.
102. Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., and Hagino, N. (1994). Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocrine Journal 41: 361-371.
103. Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., and Hagino, N. (1995). Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: 7 case reports. Dementia 6: 99-107.
104. Olichney, J. M., Schoos, B. J., Hofstetter, C. R., and Thal, L. J. (1999). Estrogen use and decline in cognition among Alzheimer's Disease patients. Neurology 52: A395.
105. O'Malley, C. A., Hautamaki, R. D., Kelley, M., and Meyer, E. M. (1987). Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, Ach synthesis, and release from rat cerebral cortical synaptosomes. Brain Research 403: 389-392.
106. Paganini-Hill, A., and Henderson, V. W. (1996). The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock drawing task in older women. Journal of the American Geriatric Society 44: 818-822.
107. Paganini-Hill, A., Ross, R. K., and Henderson, B. E. (1988). Post-menopausal oestrogen treatment and stroke: A prospective study. British Medical Association Journal 297: 519-522.
108. Palinkas, L. A., and Barrett-Connor, E. (1992). Estrogen use and depressive symptoms in postmenopausal women. Obstetrics and Gynecology 80: 30-36.
109. Palmer, A. M., and DeKosky, S. T. (1993). Monoamine neurons in aging and Alzheimer's disease. Journal Neural Transmission General Section 91: 135-159.
110. Pfaff, D. W., and Keiner, M. (1973). Atlas of estradiol concentrating cells in the central nervous system of the female rat. Journal of Comparative Neurology 151: 121-158.
111. Phillips, S. M., and Sherwin, B. B. (1992). Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendrocrinology 17: 485-495.
112. Poirier, M. F., Loo, H., Dennis, T, Le, F. G., and Scatton, B. (1985). Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle. Neuropsycholobiology 14: 165-169.
113. Polo-Kantola, P., Portin, R., Koskinen, T., Polo, O., Irjala, K., and Erkkola, R. (1997). Climacteric symptoms do not impair cognitive performances in postmenopause. Maturitas: Journal of the Climacteric and Postmenopause 27: 13-23.
114. Polo-Kantola, P., Portin, R., Polo, O., Helenius, H., Irjala, K., and Erkkola, R. (1998). The effect of short-term estrogen replacement therapy on cognition: A randomized double-blind, crossover trial in postmenopausal women. Obstetrics and Gynecology 91: 459-466.
115. Porter, M., Penny, G. C., Russell, D., Russell, E., and Templeton, A. (1996). A population based survey of women's experience of the menopause. British Journal of Obstetrics and Gynaecology 103: 1025-1028.
116. Rauramo, L., Lagerspetz, K., Engblom, P., and Punnonen, R. (1975). The effect of castration and peroral estrogen therapy on some psychological functions. Frontiers in Hormone Research 3: 94-104.
117. Reed, T., Carmelli, D., Swan, G. E., Breitner, J. C. S., Welsh, K. A., Jarvik, G. P., Deeb, S., and Auwerx, M. D. (1994). Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Archives of Neurology 51: 1189-1192.
118. Resnick, S. M., Maki, P. M., Golski, S., Kraut, M. A., and Zonderman, A. B. (1998). Estrogen effects on PET cerebral blood flow and neuropsychological performance. Hormones and Behavior 34: 171-184.
119. Resnick, S. M., Metter, E. J., and Zonderman, A. B. (1997). Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect? Neurology 49: 1491-1497.
120. Rice, M. M., Graves, A. B., McCurry, S. M., Gibbons, L. E., Bowen, J. D., McCormick, W. C., and Larson, E. B. (2000). Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame project. Archives of Internal Medicine 160: 1641-1649.
121. Rice, M. M., Graves, A. B., McCurry, S. M., and Larson, E. B. (1997). ERT and cognitive function in post-menapausal women without dementia. American Journal of Medicine 103: 26S-35S.
122. Rissman, E. F., Wersinger, S. R., Fugger, H. N., and Foster, T. C. (1999). Sex with knockout models: Behavioral studies of estrogen receptor alpha. Brain Research 835: 80-90.
123. Robinson, D., Friedman, L., Marcus, R., Tinklenberg, J., and Yesavage, J. (1994). Estrogen replacement therapy and memory in older women. Journal of the American Geriatrics Society 42: 919-922.
124. Rocca, W. A., Bonaiuto, S., Lippi, A., Luciani, P., Turtu, F., Cavarzeran, F., and Amaducci, L. (1990). Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door-to-door survey in Appignano, Macerata Province, Italy. Neurology 40: 626-631.
125. Roses, A. D. (1995). Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Annals of Neurology 38: 6-14.
126. Rudolph, I., Zimmermann, T., Kaminski, K., Jandova, K., Borovsky, B., Ahrendt, H.-J., and Golbs, S. (2000). Changes in psychic and somatic well-being and cognitive capabilities of peri-and postmenopausal women after the use of a hormone replacement drug containing estradiol valerate and levonorgestrel. Methods and Finding in Experimental and Clinical Pharmacology 22: 51-56.
127. Sano, M. (2000). Understanding the role of estrogen on cognition and dementia. Journal of Neural Transmission 59(Suppl): 223-229.
128. Sass, K. J., Spencer, D. D., Kim, J. H., Westerveld, M., Novelly, R. A., and Lencz, T. (1990). Verbal memory impairment correlates with hippocampal pyramidal cell density. Neurology 40: 1694-1697.
129. Saunders, P. T. (1998). Oestrogen receptor beta (ER beta). Reviews of Reproduction 3: 164-171.
130. Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., and Hoover, R. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283: 485-491.
131. Schmidt, R., Fazekas, F., Reinhart, B., Kapellar, P., Fazekas, G., Offenbacher, H., Eber, B., Schumacher, M., and Freidl, W. ( 1996). Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. Journal of the American Geriatrics Society 44: 1307-1313.
132. Schneider, M. A., Brotherton, P. L., and Hailes, J. (1977). The effect of exogenous oestrogens on depression in menopausal women. Medical Journal 2: 162-163.
133. Shaywitz, S. E., Shaywitz, B. A., Pugh, K. R., Fullbright, R. K., Shudlarkski, P., Mencl, W. E., Constable, R. T., Naflin, F., Palter, S. F., Marchione, K. E., Katz, L., Shankweiler, D. P., Fletcher, J. M., Lacadie, C., Keltz, M., and Gore, J. C. (1999). Effects of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281: 1197-1202.
134. Sherwin, B. B. (1988). Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoendocrinology 13: 345-357.
135. Sherwin, B. B. (1994). Estrogenic effects on memory in women. Annals of the New York Academy of Sciences 743: 756-762.
136. Sherwin, B. B. (1998). Estrogen and cognitive functioning in women. Proceedings of the Society for Experimental Biology and Medicine 217: 17-22.
137. Sherwin, B. B., and Phillips, S. M. (1990). Estrogen and cognitive functioning in surgically menopausal women. Annals of the New York Academy of Science 592: 474-475.
138. Sherwin, B. B., and Tulandi T. (1996). "Add-Back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with Leiomyomata Uteri. Journal of Clinical Endocrinology and Metabolism 81: 2545-2549.
139. Shughrue, P., Lane, M. V., and Merchenthaler, I. (1997). The comparative distribution of Eralpha and beta mRNA in the rat central nervous system. Journal of Comparative Neurology 388: 507-525.
140. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1999). Biologically active estrogen receptor-beta: Evidence from in vivo autoradiographic studies with estrogen receptor alpha-knockout mice. Endocrinology 140: 2613-2620.
141. Shughrue, P. J., and Merchenthaler, I. (2000). Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex. Frontiers in Neuroendocrinology 21: 95-101.
142. Shughrue, P., Scrimo, P. J., and Merchenthaler, I. (2000). Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain. Neuroscience 96: 41-49.
143. Shumaker, S. A., Espeland, M. A., Rapp, S. R., and Coker, L. (1999). Effects of hormone replacement therapy on cognitive aging: Women's Health Initiative Study of Cognitive Aging (WHISCA): Manual of Procedures. NIH-AG-99-04.
144. Shumaker, S. A., Reboussin, B. A., Espeland, M. A., Rapp, S. R., McBee, W. L., Dailey, M., Bowen, D., Terrell, T., Jones B. N. for the WHIMS Investigators (1998). The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Controlled Clinical Trials 19: 604-620.
145. Simerly, R. B., Chang, C., Muramatsu, M., and Swanson, L. W. (1990). Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. Journal of Comparative Neurology 294: 76-95.
146. Simpkins, J. W., Singh, M., and Bishop J. ( 1994). The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiology of Aging 15: S195-S197.
147. Slooter, A. J., Bronzova, J., Witteman, J. C., van Broeckhoven, C., Hofman, A., and van Duijn, C. (1999). Estrogen use and early onset Alzheimer's disease: A population based study. Journal of Neurology Neurosurgery and Psychiatry 67: 779-781.
148. Srivastava, R. A., Bhasin, N., and Srivastava, N. (1996). Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochemisty and Molecular Biology International 38: 91-101.
149. Srivastava, R. A., Srivastava, N., Averna, M., Lin, R. C., Korach, K. S., Lubahn, D. B., and Schonfeld, G. (1997). Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. Journal of Biological Chemistry 272: 33360-33366.
150. Stefins, D. C., Norton, M. C., Plassman, B. L., Tschanz, J. T., Wyse, B. W., Welsh-Bohmer, K. A., Anthony, J. C., and Breitner, J. C. (1999). Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. Journal of the American Geriatric Society 47: 1171-1175.
151. Stumpf, W. E., Sar, M., and Keefer, D. A. (1975). Atlas of target cells in the rat brain. In Anatomical Neuroendocrinology, Basel, Karger, pp. 104-119.
152. Sullivan, T. J., Karas, R. H., Aronovitz, M., Faller, G., Ziar, J., Smith, J., O' Donnell, T., and Mendelsohn, M. (1995). Estrogen inhibits the response-to-injury in a mouse carotid artery model. Journal of Clinical Investigation 96: 2482-2488.
153. Summer, B. E., and Fink, G. (1995). Estrogen increases the density of 5-hydroxytryptamine (2A) receptors in cerebral cortex and nucleus accumbens in the female rat. Journal of Steroid Biochemistry and Molecular Biology 54: 15-20.
154. Szklo, M., Cerhan, J., Diez-Roux, A. V., Chambless, L., Cooper, L., Folsom, A. R., Fried, L. P., Knopman, D., and Nieto, F. J. (1996). Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology 144: 1048-1057.
155. Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeaux, R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348: 429-432.
156. Teyler, T. J., and DiScenna, P. (1987). Long-term potentiation. Annual Review of Neuroscience 10: 131-161.
157. Teyler, T. J., Vardaris, R. M., Lewis, D., and Rawitch, A. B. (1980). Gonadal steriods: Effect on excitability of hippocampal pyramidal cells. Science 209: 1017-1019.
158. Toran-Allerand, C., Mrianda, R. C., Bentham, W. D., Sohrabji, F., Brown, T., Hochberg, R., and Maclusky, N. (1992). Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proceedings of the National Academy of Sciences 89: 4668-4672.
159. Trittschuh, E., Dunn, J. E., and Weintraub, S. (1999). Prose recall in non-demented women as a function of estrogen use. Journal of the American Geriatrics Society 47: S39.
160. Vanhulle, G., and Demol, R. (1976). A double blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In van Keep, P. A., Greenblatt, R. B., and Albeaux-Fernet, M. (eds.), Consensus on the Menopause Research, MTP Press, London, pp. 94-99.
161. Verghese, I., Kuslansky, G., Katz, M. J., Sliwinski, M., Crystal, H. A., Buschke, H., and Lipton, R. B. (2000). Cognitive performance in surgically menopausal women on estrogen. Neurology 55: 872-874.
162. Wang, P. N., Liao, S. Q., Liu, R. S., Liu, C. Y., Chao, H. T., Lu, S. R., Yu, H. Y., Wang, S. J., and Liu, H. C. (2000). Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology 54: 2061-2066.
163. Waring, S. C., Rocca, W. A., Peterson, R. C., O'Brien, P. C., Tangalos, E. G., and Kokmen, E. (1999). Postmenopausal estrogen replacement therapy and risk of AD: A population based study. Neurology 52: 965-970.
164. Weiland, N. G. (1992). Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131: 662-668.
165. Weiland, N., Orikasa, C., Hayashi, S., and McEwen, B. S. (1997). Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. Journal of Comparative Neurology 388: 603-612.
166. Weiss, B. L. (1987). Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. American Journal of Psychiatry 144: 386-387.
167. Wolf, O. T., Kudielka, B. M., Hellhammer, D. H., Torber, S., McEwen, B. S., and Kirschbaum, C. (1999). Two weeks of transdermal treatment in postmenopausal elderly women and its effect on memory and mood: Verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 24: 727-741.
168. Wong, M., Thompson, T. L., and Moss, R. L. (1996). Nongenomic actions of estrogen in the brain: Physiological significance and cellular mechanisms. Critical Reviews in Neurobiology 10: 189-203.
169. Woolley, C. S., Gould, E., Frankfurt, M., and McEwen, B. S. (1990). Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. Journal of Neuroscience 10: 4035-4039.
170. Woolley, C. S., and McEwen, B. S. (1992). Estradiol mediates fluctuations in hippocampal synapse density during the estrous cycle in the adult rat. Journal of Neuroscience 12: 2549-2554.
171. Woolley, C. S., and McEwen, B. S. (1993). Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. Journal of Comparative Neurology 336: 293-306.
172. Woolley, C. S., and McEwen, B. S. (1994). Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. Journal of Neuroscience 14:7680-7687.
173. Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. Journal of the American Medical Association 288: 321-333.
174. Yaffe, K., Cauley, J., Sands, L., and Browner, W. (1997). Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology 54: 1110-1114.
175. Yaffe, K., Haan, M., Byers, A., Tangen, C., and Kuller, L. (2000). Estrogen use, APOE, and cognitive decline: Evidence of gene-environmental interaction. Neurology 54: 1949-1953.
176. Yaffe, K., Krueger, K., Sarkar, S., Grady, D., Barrett-Connor, E., Cox, D. A., Nickelsen, T., and Multiple Outcomes of Raloxifene Evaluation Investigators (2001). Cognitive function in postmenopausal women treated with raloxifene. New England Journal of Medicine. 344: 1242-1244.
177. Yaffe, K., Sawaya, G., Lieberburg, I., and Grady, D. (1998). Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 279: 688-695.
178. Zee, R. F., and Trivedi, M. A. (2001). Hormone replacement therapy and cognition: Role of menopausal symptoms (Letter to the Editor). JAMA 286: 2974-2975.
179. Zee, R. F., and Trivedi, M. A. (2002). Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: A review of ongoing large-scale, long-term clinical trials. Climacteric 5: 122-134.